Plagiarism Policy
Buddha Journal of Pharmaceutical Science and Research (BJPSR)
At Buddha Journal of Pharmaceutical Sciences & Research (BJPSR), we are committed to maintaining the highest standards of academic integrity and ethical publishing. Plagiarism in any form undermines the credibility of scholarly work and is considered a serious breach of ethical research practices. To uphold these standards, BJPSR follows a strict plagiarism policy to ensure that all published content is original, properly cited, and academically sound.
Similarity Threshold
BJPSR permits a maximum similarity index of 15%, acknowledging that minor overlap may occur due to commonly used terms or essential references. However, any manuscript exceeding this threshold, or containing instances of unacknowledged or improperly attributed content, will be subject to rejection.
All submitted manuscripts undergo a comprehensive plagiarism screening using advanced similarity detection software to identify overlap with previously published literature and other available sources.
Consequences of Plagiarism
If plagiarism is detected at any stage of the review or publication process:
Actions Taken:
- Minor overlap may result in the manuscript being returned to the author for revision and proper citation.
- Significant or intentional plagiarism will lead to immediate rejection of the manuscript.
- In severe cases, authors may face further actions, including blacklisting from future submissions to BJPSR.
Authors are responsible for ensuring that all borrowed material—text, data, figures, or ideas—is fully acknowledged and correctly referenced.
Author Declaration
By submitting a manuscript to BJPSR, authors affirm that the work is original, ethically prepared, and free from plagiarism. They also confirm that all sources have been accurately cited and that the manuscript adheres to the journal's ethical and academic standards.